The DOI matches its Crossref record; 359 of the 359 references it cites were found in a registry or an index.
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review)
Open accessAbstract
MicroRNA (miRNA or miR) therapeutics in cancer are based on targeting or mimicking miRNAs involved in cancer onset, progression, angiogenesis, epithelial-mesenchymal transition and metastasis. Several studies conclusively have demonstrated that miRNAs are deeply involved in tumor onset and progression, either behaving as tumor-promoting miRNAs (oncomiRNAs and metastamiRNAs) or as tumor suppressor miRNAs. This review focuses on the most promising examples potentially leading to the development of anticancer, miRNA-based therapeutic protocols. The inhibition of miRNA activity can be readily achieved by the use of miRNA inhibitors and oligomers, including RNA, DNA and DNA analogues (miRNA antisense therapy), small molecule inhibitors, miRNA sponges or through miRNA masking. On the contrary, the enhancement of miRNA function (miRNA replacement therapy) can be achieved by the use of modified miRNA mimetics, such as plasmid or lentiviral vectors carrying miRNA sequences. Combination strategies have been recently developed based on the observation that i) the combined administration of different antagomiR molecules induces greater antitumor effects and ii) some anti-miR molecules can sensitize drug-resistant tumor cell lines to therapeutic drugs. In this review, we discuss two additional issues: i) the combination of miRNA replacement therapy with drug administration and ii) the combination of antagomiR and miRNA replacement therapy. One of the solid results emerging from different independent studies is that miRNA replacement therapy can enhance the antitumor effects of the antitumor drugs. The second important conclusion of the reviewed studies is that the combination of anti-miRNA and miRNA replacement strategies may lead to excellent results, in terms of antitumor effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
11 retracted
RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis
Valastyan, S., Reinhardt, F., Benaich, N., Calogrias, D., Szász, A. M., Wang, Z. C., Brock, J. E., Richardson, A. L., & Weinberg, R. A. (2009) · Cell · doi:10.1016/j.cell.2009.03.047 · Cited by 820
RetractedKong, W., He, L., Coppola, M., Guo, J., Esposito, N. N., Coppola, D., & Cheng, J. Q. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.101055 · Cited by 377
RetractedKrzeszinski, J. Y., Wei, W., Huynh, H., Jin, Z., Wang, X., Chang, T.-C., Xie, X.-J., He, L., Mangala, L. S., Lopez-Berestein, G., et al. (2014) · Nature · doi:10.1038/nature13375 · Cited by 303
RetractedGao, P., Xing, A.-Y., Zhou, G.-Y., Zhang, T.-G., Zhang, J.-P., Gao, C., Li, H., & Shi, D.-B. (2012) · Oncogene · doi:10.1038/onc.2012.61 · Cited by 150
RetractedYang, T., Lu, X., Wu, T., Ding, D.-D., Zhao, Z., Chen, G., Xie, X., Li, B., Wei, Y., Guo, L., et al. (2014) · Cancer Science · doi:10.1111/cas.12351 · Cited by 132
RetractedLiang, Z., Ahn, J. M., Guo, D., Votaw, J. R., & Shim, H. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0936-9 · Cited by 98
RetractedWang, L., Yao, J., Shi, X., Hu, L., Li, Z., Song, T., & Huang, C. Y. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-448 · Cited by 92
RetractedMicroRNA-33b Suppresses Migration and Invasion by Targeting c-Myc in Osteosarcoma Cells
Xu, N., Li, Z., Yu, Z., Yan, F., Liu, Y., Lu, X., & Yang, W.-L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115300 · Cited by 61
RetractedMicroRNA-493 Suppresses Tumor Growth, Invasion and Metastasis of Lung Cancer by Regulating E2F1
Gu, Y., Cheng, Y., Song, Y., Zhang, Z., Deng, M., Wang, C., Zheng, G., & He, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102602 · Cited by 58
RetractedmiR-126 inhibits papillary thyroid carcinoma growth by targeting LRP6
Wen, Q., Zhao, J., Bai, L., WANG, T., Zhang, H., & Ma, Q. (2015) · Oncology Reports · doi:10.3892/or.2015.4165 · Cited by 33
RetractedShao, J., Cao, J., Liu, Y., Mei, H., Zhang, Y., & Xu, W. (2015) · FEBS Open Bio · doi:10.1016/j.fob.2015.10.009 · Cited by 30
RetractedOncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
miRBase: annotating high confidence microRNAs using deep sequencing data
Kozomara, A., & Griffiths-Jones, S. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1181 · Cited by 5,073
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
The widespread regulation of microRNA biogenesis, function and decay
Krol, J., Loedige, I., & Filipowicz, W. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2843 · Cited by 4,672
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
Calin, G. A., Sevignani, C., Dumitru, C. D., Hyslop, T., Noch, E., Yendamuri, S., Shimizu, M., Rattan, S., Bullrich, F., Negrini, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307323101 · Cited by 4,095
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
miRBase: microRNA sequences, targets and gene nomenclature
Griffiths-Jones, S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj112 · Cited by 3,950
Mammalian microRNAs predominantly act to decrease target mRNA levels
Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
RAS Is Regulated by the let-7 MicroRNA Family
Johnson, S. M., Grosshans, H., Shingara, J., Byrom, M., Jarvis, R., Cheng, A., Labourier, E., Reinert, K. L., Brown, D., & Slack, F. J. (2005) · Cell · doi:10.1016/j.cell.2005.01.014 · Cited by 3,656
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
The MicroRNA Spectrum in 12 Body Fluids
Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., How Huang, K., Jen Lee, M., Galas, D. J., & Wang, K. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147405 · Cited by 2,477
A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia
Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., Iorio, M. V., Visone, R., Sever, N. I., Fabbri, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050995 · Cited by 2,403
Takamizawa, J., Konishi, H., Yanagisawa, K., Tomida, S., Osada, H., Endoh, H., Harano, T., Yatabe, Y., Nagino, M., Nimura, Y., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0637 · Cited by 2,354
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells
Ebert, M. S., Neilson, J. R., & Sharp, P. A. (2007) · Nature Methods · doi:10.1038/nmeth1079 · Cited by 2,108
Asangani, I. A., Rasheed, S. A. K., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., & Allgayer, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210856 · Cited by 1,882
Endogenous human microRNAs that suppress breast cancer metastasis
Tavazoie, S. F., Alarcón, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L., & Massagué, J. (2008) · Nature · doi:10.1038/nature06487 · Cited by 1,857
Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., Liu, S., Alder, H., Costinean, S., Fernandez-Cymering, C., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707628104 · Cited by 1,673
Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800074200 · Cited by 1,645
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · cited 1×
“The inhibition of miRNA activity can be readily achieved by the use of miRNA inhibitors and oligomers, including RNA, DNA and DNA analogues (miRNA antisense therapy) (45-47), small molecule inhibitors, locked nucleic acids (LNAs) (48-53), peptide nucleic acids (PNAs) (54-57), morpholinos (58-60), miRNA sponges (61-67)…”
BackgroundCancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Liu, C., Kelnar, K., Liu, B., Chen, X., Calhoun-Davis, T., Li, H., Patrawala, L., Yan, H., Jeter, C., Honorio, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2284 · Cited by 1,400
MicroRNA Signatures in Human Ovarian Cancer
Iorio, M. V., Visone, R., Di Leva, G., Donati, V., Petrocca, F., Casalini, P., Taccioli, C., Volinia, S., Liu, C.-G., Alder, H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1936 · Cited by 1,394
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Ma, L., Young, J., Prabhala, H., Pan, E., Mestdagh, P., Muth, D., Teruya-Feldstein, J., Reinhardt, F., Onder, T. T., Valastyan, S., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2024 · Cited by 1,336
Pervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
The tumor suppressor microRNA let-7 represses the HMGA2 oncogene
Lee, Y. S., & Dutta, A. (2007) · Genes & Development · doi:10.1101/gad.1540407 · Cited by 1,152
Frankel, L. B., Christoffersen, N. R., Jacobsen, A., Lindow, M., Krogh, A., & Lund, A. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707224200 · Cited by 1,141
p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes
Bommer, G. T., Gerin, I., Feng, Y., Kaczorowski, A. J., Kuick, R., Love, R. E., Zhai, Y., Giordano, T. J., Qin, Z. S., Moore, B. B., et al. (2007) · Current Biology · doi:10.1016/j.cub.2007.06.068 · Cited by 1,123
Fong, M. Y., Zhou, W., Liu, L., Alontaga, A. Y., Chandra, M., Ashby, J., Chow, A., O’Connor, S. T. F., Li, S., Chin, A. R., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3094 · Cited by 1,118
Disrupting the Pairing Between let-7 and Hmga2 Enhances Oncogenic Transformation
Mayr, C., Hemann, M. T., & Bartel, D. P. (2007) · Science · doi:10.1126/science.1137999 · Cited by 1,100
MicroRNA-21 Targets the Tumor Suppressor Gene Tropomyosin 1 (TPM1)
Zhu, S., Si, M.-L., Wu, H., & Mo, Y.-Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611393200 · Cited by 1,090
Yang, H., Kong, W., He, L., Zhao, J.-J., O'Donnell, J. D., Wang, J., Wenham, R. M., Coppola, D., Kruk, P. A., Nicosia, S. V., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2488 · Cited by 1,051
Principles of Tumor Suppression
Sherr, C. J. (2004) · Cell · doi:10.1016/s0092-8674(03)01075-4 · Cited by 1,034
The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
Bonci, D., Coppola, V., Musumeci, M., Addario, A., Giuffrida, R., Memeo, L., D'Urso, L., Pagliuca, A., Biffoni, M., Labbaye, C., et al. (2008) · Nature Medicine · doi:10.1038/nm.1880 · Cited by 989
MicroRNA Expression Profiling in Prostate Cancer
Porkka, K. P., Pfeiffer, M. J., Waltering, K. K., Vessella, R. L., Tammela, T. L. J., & Visakorpi, T. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0533 · Cited by 899
mir-29 regulates Mcl-1 protein expression and apoptosis
Mott, J. L., Kobayashi, S., Bronk, S. F., & Gores, G. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210436 · Cited by 834
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
Cheng, C. J., Bahal, R., Babar, I. A., Pincus, Z., Barrera, F., Liu, C., Svoronos, A., Braddock, D. T., Glazer, P. M., Engelman, D. M., et al. (2015) · Nature · doi:10.1038/nature13905 · Cited by 823
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
Tsai, W.-C., Hsu, S.-D., Hsu, C.-S., Lai, T.-C., Chen, S.-J., Shen, R., Huang, Y., Chen, H.-C., Lee, C.-H., Tsai, T.-F., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63455 · Cited by 814
MicroRNA Let-7a Down-regulates MYC and Reverts MYC-Induced Growth in Burkitt Lymphoma Cells
Sampson, V. B., Rong, N. H., Han, J., Yang, Q., Aris, V., Soteropoulos, P., Petrelli, N. J., Dunn, S. P., & Krueger, L. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2462 · Cited by 805
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer
Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Körner, H., Knyazev, P., Diebold, J., & Hermeking, H. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6533 · Cited by 784
Garzon, R., Liu, S., Fabbri, M., Liu, Z., Heaphy, C. E. A., Callegari, E., Schwind, S., Pang, J., Yu, J., Muthusamy, N., et al. (2009) · Blood · doi:10.1182/blood-2008-07-170589 · Cited by 781
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Ma, L., Reinhardt, F., Pan, E., Soutschek, J., Bhat, B., Marcusson, E. G., Teruya-Feldstein, J., Bell, G. W., & Weinberg, R. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1618 · Cited by 772
MicroRNA sponges: Progress and possibilities
Ebert, M. S., & Sharp, P. A. (2010) · RNA · doi:10.1261/rna.2414110 · Cited by 762
Galardi, S., Mercatelli, N., Giorda, E., Massalini, S., Frajese, G. V., Ciafre, S. A., & Farace, M. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701805200 · Cited by 749
miR-34 – a microRNA replacement therapy is headed to the clinic
Bader, A. G. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00120 · Cited by 728
Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells
Chekulaeva, M., & Filipowicz, W. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.04.009 · Cited by 685
Jiang, S., Zhang, H.-W., Lu, M.-H., He, X.-H., Li, Y., Gu, H., Liu, M.-F., & Wang, E.-D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4250 · Cited by 679
Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
Wiggins, J. F., Ruffino, L., Kelnar, K., Omotola, M., Patrawala, L., Brown, D., & Bader, A. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0655 · Cited by 677
Trang, P., Wiggins, J. F., Daige, C. L., Cho, C., Omotola, M., Brown, D., Weidhaas, J. B., Bader, A. G., & Slack, F. J. (2011) · Molecular Therapy · doi:10.1038/mt.2011.48 · Cited by 667
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives
Aqeilan, R. I., Calin, G. A., & Croce, C. M. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.69 · Cited by 648
Korpal, M., Ell, B. J., Buffa, F. M., Ibrahim, T., Blanco, M. A., Celià-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2401 · Cited by 636
MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia
Garzon, R., Volinia, S., Liu, C.-G., Fernandez-Cymering, C., Palumbo, T., Pichiorri, F., Fabbri, M., Coombes, K., Alder, H., Nakamura, T., et al. (2008) · Blood · doi:10.1182/blood-2007-07-098749 · Cited by 632
Silencing of microRNA families by seed-targeting tiny LNAs
Obad, S., dos Santos, C. O., Petri, A., Heidenblad, M., Broom, O., Ruse, C., Fu, C., Lindow, M., Stenvang, J., Straarup, E. M., et al. (2011) · Nature Genetics · doi:10.1038/ng.786 · Cited by 627
Development of microRNA therapeutics is coming of age
van Rooij, E., & Kauppinen, S. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201100899 · Cited by 625
Bhaumik, D., Scott, G. K., Schokrpur, S., Patil, C. K., Campisi, J., & Benz, C. C. (2008) · Oncogene · doi:10.1038/onc.2008.171 · Cited by 622
The Promise of MicroRNA Replacement Therapy
Bader, A. G., Brown, D., & Winkler, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2010 · Cited by 617
miRCancer: a microRNA–cancer association database constructed by text mining on literature
Xie, B., Ding, Q., Han, H., & Wu, D. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt014 · Cited by 572
Effects of Microrna-29 on Apoptosis, Tumorigenicity, and Prognosis of Hepatocellular Carcinoma
Xiong, Y., Fang, J.-H., Yun, J.-P., Yang, J., Zhang, Y., Jia, W.-H., & Zhuang, S.-M. (2010) · Hepatology · doi:10.1002/hep.23380 · Cited by 563
Segura, M. F., Hanniford, D., Menendez, S., Reavie, L., Zou, X., Alvarez-Diaz, S., Zakrzewski, J., Blochin, E., Rose, A., Bogunovic, D., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808263106 · Cited by 542
Yang, P., Li, Q.-J., Feng, Y., Zhang, Y., Markowitz, G. J., Ning, S., Deng, Y., Zhao, J., Jiang, S., Yuan, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.023 · Cited by 536
A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
Png, K. J., Halberg, N., Yoshida, M., & Tavazoie, S. F. (2012) · Nature · doi:10.1038/nature10661 · Cited by 531
MicroRNAome genome: A treasure for cancer diagnosis and therapy
Berindan‐Neagoe, I., Monroig, P. D. C., Pasculli, B., & Calin, G. A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21244 · Cited by 522
Lee, D. Y., Deng, Z., Wang, C.-H., & Yang, B. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706901104 · Cited by 519
Target Protectors Reveal Dampening and Balancing of Nodal Agonist and Antagonist by miR-430
Choi, W.-Y., Giraldez, A. J., & Schier, A. F. (2007) · Science · doi:10.1126/science.1147535 · Cited by 517
Krol, J., Busskamp, V., Markiewicz, I., Stadler, M. B., Ribi, S., Richter, J., Duebel, J., Bicker, S., Fehling, H. J., Schübeler, D., et al. (2010) · Cell · doi:10.1016/j.cell.2010.03.039 · Cited by 470
Practical Aspects of microRNA Target Prediction
M. Witkos, T., Koscianska, E., & J. Krzyzosiak, W. (2011) · Current Molecular Medicine · doi:10.2174/156652411794859250 · Cited by 466
miR-296 Regulates Growth Factor Receptor Overexpression in Angiogenic Endothelial Cells
Würdinger, T., Tannous, B. A., Saydam, O., Skog, J., Grau, S., Soutschek, J., Weissleder, R., Breakefield, X. O., & Krichevsky, A. M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.005 · Cited by 463
MicroRNA 29b functions in acute myeloid leukemia
Garzon, R., Heaphy, C. E. A., Havelange, V., Fabbri, M., Volinia, S., Tsao, T., Zanesi, N., Kornblau, S. M., Marcucci, G., Calin, G. A., et al. (2009) · Blood · doi:10.1182/blood-2009-03-211938 · Cited by 459
Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer
Tsang, W. P., Ng, E. K. O., Ng, S. S. M., Jin, H., Yu, J., Sung, J. J. Y., & Kwok, T. T. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp181 · Cited by 456
Kano, M., Seki, N., Kikkawa, N., Fujimura, L., Hoshino, I., Akutsu, Y., Chiyomaru, T., Enokida, H., Nakagawa, M., & Matsubara, H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25284 · Cited by 441
MiR-218 Inhibits Invasion and Metastasis of Gastric Cancer by Targeting the Robo1 Receptor
Tie, J., Pan, Y., Zhao, L., Wu, K., Liu, J., Sun, S., Guo, X., Wang, B., Gang, Y., Zhang, Y., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000879 · Cited by 439
Chemical modification and design of anti-miRNA oligonucleotides
Lennox, K. A., & Behlke, M. A. (2011) · Gene Therapy · doi:10.1038/gt.2011.100 · Cited by 433
Cheng, H., Zhang, L., Cogdell, D. E., Zheng, H., Schetter, A. J., Nykter, M., Harris, C. C., Chen, K., Hamilton, S. R., & Zhang, W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017745 · Cited by 430
Chen, D., Sun, Y., Wei, Y., Zhang, P., Rezaeian, A. H., Teruya-Feldstein, J., Gupta, S., Liang, H., Lin, H.-K., Hung, M.-C., et al. (2012) · Nature Medicine · doi:10.1038/nm.2940 · Cited by 413
Londin, E., Loher, P., Telonis, A. G., Quann, K., Clark, P., Jing, Y., Hatzimichael, E., Kirino, Y., Honda, S., Lally, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420955112 · Cited by 404
MicroRNA Replacement Therapy for miR-145 and miR-33a Is Efficacious in a Model of Colon Carcinoma
Ibrahim, A. F., Weirauch, U., Thomas, M., Grünweller, A., Hartmann, R. K., & Aigner, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4645 · Cited by 400
Sengupta, S., den Boon, J. A., Chen, I.-H., Newton, M. A., Stanhope, S. A., Cheng, Y.-J., Chen, C.-J., Hildesheim, A., Sugden, B., & Ahlquist, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801130105 · Cited by 398
Antagomir-17-5p Abolishes the Growth of Therapy-Resistant Neuroblastoma through p21 and BIM
Fontana, L., Fiori, M. E., Albini, S., Cifaldi, L., Giovinazzi, S., Forloni, M., Boldrini, R., Donfrancesco, A., Federici, V., Giacomini, P., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002236 · Cited by 385
Loss of mir-146a function in hormone-refractory prostate cancer
Lin, S.-L., Chiang, A., Chang, D., & Ying, S.-Y. (2008) · RNA · doi:10.1261/rna.874808 · Cited by 382
Zheng, F., Liao, Y.-J., Cai, M.-Y., Liu, Y.-H., Liu, T.-H., Chen, S.-P., Bian, X.-W., Guan, X.-Y., Lin, M. C., Zeng, Y.-X., et al. (2012) · Gut · doi:10.1136/gut.2011.239145 · Cited by 376
Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?
Weiler, J., Hunziker, J., & Hall, J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302654 · Cited by 371
Zhang, H., Cai, K., Wang, J., Wang, X., Cheng, K., Shi, F., Jiang, L., Zhang, Y., & Dou, J. (2014) · Stem Cells · doi:10.1002/stem.1795 · Cited by 368
Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let‐7
Dangi‐Garimella, S., Yun, J., Eves, E. M., Newman, M., Erkeland, S. J., Hammond, S. M., Minn, A. J., & Rosner, M. R. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.294 · Cited by 363
Gandellini, P., Folini, M., Longoni, N., Pennati, M., Binda, M., Colecchia, M., Salvioni, R., Supino, R., Moretti, R., Limonta, P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2894 · Cited by 358
Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications
Brown, B. D., & Naldini, L. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2628 · Cited by 336
Pogribny, I. P., Filkowski, J. N., Tryndyak, V. P., Golubov, A., Shpyleva, S. I., & Kovalchuk, O. (2010) · International Journal of Cancer · doi:10.1002/ijc.25191 · Cited by 334
Adult-specific functions of animal microRNAs
Sun, K., & Lai, E. C. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3471 · Cited by 334
Shin, K.-J., Wall, E. A., Zavzavadjian, J. R., Santat, L. A., Liu, J., Hwang, J.-I., Rebres, R., Roach, T., Seaman, W., Simon, M. I., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606179103 · Cited by 332
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
Fujita, Y., Kojima, K., Hamada, N., Ohhashi, R., Akao, Y., Nozawa, Y., Deguchi, T., & Ito, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.09.086 · Cited by 331
miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
Garofalo, M., Quintavalle, C., Romano, G., M. Croce, C., & Condorelli, G. (2012) · Current Molecular Medicine · doi:10.2174/156652412798376170 · Cited by 331
Yan, L. X., Wu, Q. N., Zhang, Y., Li, Y. Y., Liao, D. Z., Hou, J. H., Fu, J., Zeng, M. S., Yun, J. P., Wu, Q. L., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2803 · Cited by 323
MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma
Zhang, C.-Z., Zhang, J.-X., Zhang, A.-L., Shi, Z.-D., Han, L., Jia, Z.-F., Yang, W.-D., Wang, G.-X., Jiang, T., You, Y.-P., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-229 · Cited by 314
MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8
Fang, L., Deng, Z., Shatseva, T., Yang, J., Peng, C., Du, W. W., Yee, A. J., Ang, L. C., He, C., Shan, S. W., et al. (2011) · Oncogene · doi:10.1038/onc.2010.465 · Cited by 307
Haraguchi, T., Ozaki, Y., & Iba, H. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp040 · Cited by 305
Prediction of microRNA targets
Mazière, P., & Enright, A. J. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.04.002 · Cited by 304
Targeting of mRNAs by multiple miRNAs: the next step
Peter, M. E. (2010) · Oncogene · doi:10.1038/onc.2010.59 · Cited by 303
Metastamir: The Field of Metastasis-Regulatory microRNA Is Spreading
Hurst, D. R., Edmonds, M. D., & Welch, D. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2111 · Cited by 299
The MYCN oncogene is a direct target of miR-34a
Wei, J. S., Song, Y. K., Durinck, S., Chen, Q.-R., Cheuk, A. T. C., Tsang, P., Zhang, Q., Thiele, C. J., Slack, A., Shohet, J., et al. (2008) · Oncogene · doi:10.1038/onc.2008.154 · Cited by 296
MicroRNA-10b Promotes Migration and Invasion through KLF4 in Human Esophageal Cancer Cell Lines
Tian, Y., Luo, A., Cai, Y., Su, Q., Ding, F., Chen, H., & Liu, Z. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.062877 · Cited by 295
TGF-β upregulates miR-181a expression to promote breast cancer metastasis
Taylor, M. A., Sossey-Alaoui, K., Thompson, C. L., Danielpour, D., & Schiemann, W. P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64946 · Cited by 288
miR-7 Suppresses Brain Metastasis of Breast Cancer Stem-Like Cells By Modulating KLF4
Okuda, H., Xing, F., Pandey, P. R., Sharma, S., Watabe, M., Pai, S. K., Mo, Y.-Y., Iiizumi-Gairani, M., Hirota, S., Liu, Y., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2037 · Cited by 285
Lin, C.-W., Chang, Y.-L., Chang, Y.-C., Lin, J.-C., Chen, C.-C., Pan, S.-H., Wu, C.-T., Chen, H.-Y., Yang, S.-C., Hong, T.-M., et al. (2013) · Nature Communications · doi:10.1038/ncomms2876 · Cited by 281
MicroRNA control of epithelial–mesenchymal transition and metastasis
Zhang, J., & Ma, L. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9368-6 · Cited by 273
Keklikoglou, I., Koerner, C., Schmidt, C., Zhang, J. D., Heckmann, D., Shavinskaya, A., Allgayer, H., Gückel, B., Fehm, T., Schneeweiss, A., et al. (2012) · Oncogene · doi:10.1038/onc.2011.571 · Cited by 273
MicroRNA-301 Mediates Proliferation and Invasion in Human Breast Cancer
Shi, W., Gerster, K., Alajez, N. M., Tsang, J., Waldron, L., Pintilie, M., Hui, A. B., Sykes, J., P'ng, C., Miller, N., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3369 · Cited by 266
Møller, H. G., Rasmussen, A. P., Andersen, H. H., Johnsen, K. B., Henriksen, M., & Duroux, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8349-7 · Cited by 266
microRNA‐214 contributes to melanoma tumour progression through suppression of TFAP2C
Penna, E., Orso, F., Cimino, D., Tenaglia, E., Lembo, A., Quaglino, E., Poliseno, L., Haimovic, A., Osella‐Abate, S., De Pittà, C., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.102 · Cited by 261
Regulation of p27Kip1by miRNA 221/222 in Glioblastoma
Gillies, J. K., & Lorimer, I. A. J. (2007) · Cell Cycle · doi:10.4161/cc.6.16.4526 · Cited by 259
Evidence for the biogenesis of more than 1,000 novel human microRNAs
Friedländer, M. R., Lizano, E., Houben, A. J., Bezdan, D., Báñez-Coronel, M., Kudla, G., Mateu-Huertas, E., Kagerbauer, B., González, J., Chen, K. C., et al. (2014) · Genome Biology · doi:10.1186/gb-2014-15-4-r57 · Cited by 256
Aging and chronic DNA damage response activate a regulatory pathway involving miR‐29 and p53
Ugalde, A. P., Ramsay, A. J., de la Rosa, J., Varela, I., Mariño, G., Cadiñanos, J., Lu, J., Freije, J. M., & López‐Otín, C. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.124 · Cited by 254
microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers
Nohata, N., Hanazawa, T., Enokida, H., & Seki, N. (2012) · Oncotarget · doi:10.18632/oncotarget.424 · Cited by 253
Mercatelli, N., Coppola, V., Bonci, D., Miele, F., Costantini, A., Guadagnoli, M., Bonanno, E., Muto, G., Frajese, G. V., De Maria, R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004029 · Cited by 250
Kapinas, K., Kessler, C. B., & Delany, A. M. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22243 · Cited by 249
Let-7 Prevents Early Cancer Progression by Suppressing Expression of the Embryonic Gene HMGA2
Park, S.-M., Shell, S., Radjabi, A. R., Schickel, R., Feig, C., Boyerinas, B., Dinulescu, D. M., Lengyel, E., & Peter, M. E. (2007) · Cell Cycle · doi:10.4161/cc.6.21.4845 · Cited by 242
Small RNA combination therapy for lung cancer
Xue, W., Dahlman, J. E., Tammela, T., Khan, O. F., Sood, S., Dave, A., Cai, W., Chirino, L. M., Yang, G. R., Bronson, R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412686111 · Cited by 242
miR-449 inhibits cell proliferation and is down-regulated in gastric cancer
Bou Kheir, T., Futoma-Kazmierczak, E., Jacobsen, A., Krogh, A., Bardram, L., Hother, C., Grønbæk, K., Federspiel, B., Lund, A. H., & Friis-Hansen, L. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-29 · Cited by 240
Micro RNA mimicry blocks pulmonary fibrosis
Montgomery, R. L., Yu, G., Latimer, P. A., Stack, C., Robinson, K., Dalby, C. M., Kaminski, N., & van Rooij, E. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303604 · Cited by 238
Current State of Circulating MicroRNAs as Cancer Biomarkers
He, Y., Lin, J., Kong, D., Huang, M., Xu, C., Kim, T.-K., Etheridge, A., Luo, Y., Ding, Y., & Wang, K. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.241190 · Cited by 232
MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1
Yang, S., Li, Y., Gao, J., Zhang, T., Li, S., Luo, A., Chen, H., Ding, F., Wang, X., & Liu, Z. (2013) · Oncogene · doi:10.1038/onc.2012.432 · Cited by 228
MicroRNAs in B-cell lymphomas: how a complex biology gets more complex
Musilova, K., & Mraz, M. (2015) · Leukemia · doi:10.1038/leu.2014.351 · Cited by 227
miRNA Therapeutics: A New Class of Drugs with Potential Therapeutic Applications in the Heart
Bernardo, B. C., Ooi, J. Y., Lin, R. C., & McMullen, J. R. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.107 · Cited by 226
An updated role of microRNA-124 in central nervous system disorders: a review
Sun, Y., Luo, Z.-M., Guo, X.-M., Su, D.-F., & Liu, X. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00193 · Cited by 223
Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer
Wu, Y., Crawford, M., Mao, Y., Lee, R. J., Davis, I. C., Elton, T. S., Lee, L. J., & Nana-Sinkam, S. P. (2013) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2013.14 · Cited by 223
miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma
Kouri, F. M., Hurley, L. A., Daniel, W. L., Day, E. S., Hua, Y., Hao, L., Peng, C.-Y., Merkel, T. J., Queisser, M. A., Ritner, C., et al. (2015) · Genes & Development · doi:10.1101/gad.257394.114 · Cited by 220
MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a
Zhang, Y., Chao, T., Li, R., Liu, W., Chen, Y., Yan, X., Gong, Y., Yin, B., Liu, W., Qiang, B., et al. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0403-6 · Cited by 218
Efficient inhibition of miR-155 function in vivo by peptide nucleic acids
Fabani, M. M., Abreu-Goodger, C., Williams, D., Lyons, P. A., Torres, A. G., Smith, K. G. C., Enright, A. J., Gait, M. J., & Vigorito, E. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq160 · Cited by 214
The role of miRNA-29 family in cancer
Wang, Y., Zhang, X., Li, H., Yu, J., & Ren, X. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2012.11.004 · Cited by 209
Integrin β3 expression is regulated by let-7a miRNA in malignant melanoma
Müller, D. W., & Bosserhoff, A.-K. (2008) · Oncogene · doi:10.1038/onc.2008.282 · Cited by 206
Buechner, J., Tømte, E., Haug, B. H., Henriksen, J. R., Løkke, C., Flægstad, T., & Einvik, C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.220 · Cited by 201
The utility of LNA in microRNA-based cancer diagnostics and therapeutics
Stenvang, J., Silahtaroglu, A. N., Lindow, M., Elmen, J., & Kauppinen, S. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.01.004 · Cited by 198
Leucci, E., Cocco, M., Onnis, A., De Falco, G., van Cleef, P., Bellan, C., van Rijk, A., Nyagol, J., Byakika, B., Lazzi, S., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2410 · Cited by 198
Therapeutic Delivery of miR-200c Enhances Radiosensitivity in Lung Cancer
Cortez, M. A., Valdecanas, D., Zhang, X., Zhan, Y., Bhardwaj, V., Calin, G. A., Komaki, R., Giri, D. K., Quini, C. C., Wolfe, T., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.79 · Cited by 196
Therapeutic potential for microRNAs
Esau, C. C., & Monia, B. P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.007 · Cited by 195
Huang, X., Schwind, S., Yu, B., Santhanam, R., Wang, H., Hoellerbauer, P., Mims, A., Klisovic, R., Walker, A. R., Chan, K. K., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3191 · Cited by 193
Pekarsky, Y., & Croce, C. M. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.87 · Cited by 186
Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma
Köberle, V., Kronenberger, B., Pleli, T., Trojan, J., Imelmann, E., Peveling-Oberhag, J., Welker, M.-W., Elhendawy, M., Zeuzem, S., Piiper, A., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.06.002 · Cited by 184
MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer
Hudson, R. S., Yi, M., Esposito, D., Watkins, S. K., Hurwitz, A. A., Yfantis, H. G., Lee, D. H., Borin, J. F., Naslund, M. J., Alexander, R. B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1222 · Cited by 184
Metastamirs: a stepping stone towards improved cancer management
White, N. M. A., Fatoohi, E., Metias, M., Jung, K., Stephan, C., & Yousef, G. M. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.173 · Cited by 184
PDGF and PDGF receptors in glioma
Nazarenko, I., Hede, S.-M., He, X., Hedrén, A., Thompson, J., Lindström, M. S., & Nistér, M. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.665097 · Cited by 183
miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7
Sun, Y., Bai, Y., Zhang, F., Wang, Y., Guo, Y., & Guo, L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.098 · Cited by 182
Fernandez, S., Risolino, M., Mandia, N., Talotta, F., Soini, Y., Incoronato, M., Condorelli, G., Banfi, S., & Verde, P. (2015) · Oncogene · doi:10.1038/onc.2014.267 · Cited by 182
Circulating biomarkers for gliomas
Westphal, M., & Lamszus, K. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.171 · Cited by 181
Park, J.-K., Henry, J. C., Jiang, J., Esau, C., Gusev, Y., Lerner, M. R., Postier, R. G., Brackett, D. J., & Schmittgen, T. D. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.065 · Cited by 178
Ueda, R., Kohanbash, G., Sasaki, K., Fujita, M., Zhu, X., Kastenhuber, E. R., McDonald, H. A., Potter, D. M., Hamilton, R. L., Lotze, M. T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811817106 · Cited by 176
Quintavalle, C., Garofalo, M., Zanca, C., Romano, G., Iaboni, M., del Basso De Caro, M., Martinez-Montero, J. C., Incoronato, M., Nuovo, G., Croce, C. M., et al. (2012) · Oncogene · doi:10.1038/onc.2011.280 · Cited by 174
Su, R., Lin, H.-S., Zhang, X.-H., Yin, X.-L., Ning, H.-M., Liu, B., Zhai, P.-F., Gong, J.-N., Shen, C., Song, L., et al. (2015) · Oncogene · doi:10.1038/onc.2014.274 · Cited by 173
Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
Fayyad-Kazan, H., Bitar, N., Najar, M., Lewalle, P., Fayyad-Kazan, M., Badran, R., Hamade, E., Daher, A., Hussein, N., ELDirani, R., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-31 · Cited by 173
Sarkar, S., Dubaybo, H., Ali, S. S., Goncalves, P. H., Kollepara, S. L. S., Sethi, S. N., Philip, P. A., & Li, Y. (2013) · Europe PMC (PubMed Central) · Cited by 170
A Genetic Screen Implicates miRNA-372 and miRNA-373 as Oncogenes in Testicular Germ Cell Tumors
Voorhoeve, P. M., Sage, C. L., Schrier, M., Gillis, A. J. M., Stoop, H., Nagel, R., Liu, Y.-P., Duijse, J. V., Drost, J., Griekspoor, A., et al. (2007) · Advances In Experimental Medicine And Biology · doi:10.1007/978-0-387-69116-9_2 · Cited by 170
MicroRNAs as gatekeepers of apoptosis
Subramanian, S., & Steer, C. J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22066 · Cited by 170
Taniguchi, K., Sugito, N., Kumazaki, M., Shinohara, H., Yamada, N., Nakagawa, Y., Ito, Y., Otsuki, Y., Uno, B., Uchiyama, K., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.03.026 · Cited by 163
MiR-128 Inhibits Tumor Growth and Angiogenesis by Targeting p70S6K1
Shi, Z.-M., Wang, J., Yan, Z., You, Y.-P., Li, C.-Y., Qian, X., Yin, Y., Zhao, P., Wang, Y.-Y., Wang, X.-F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032709 · Cited by 160
miR-23b* targets proline oxidase, a novel tumor suppressor protein in renal cancer
Liu, W., Zabirnyk, O., Wang, H., Shiao, Y.-H., Nickerson, M. L., Khalil, S., Anderson, L. M., Perantoni, A. O., & Phang, J. M. (2010) · Oncogene · doi:10.1038/onc.2010.237 · Cited by 160
Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment
Nishimura, M., Jung, E.-J., Shah, M. Y., Lu, C., Spizzo, R., Shimizu, M., Han, H. D., Ivan, C., Rossi, S., Zhang, X., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0159 · Cited by 160
Zhang, J.-P., Zeng, C., Xu, L., Gong, J., Fang, J.-H., & Zhuang, S.-M. (2014) · Oncogene · doi:10.1038/onc.2013.369 · Cited by 160
Cimino, D., Pittà, C. D., Orso, F., Zampini, M., Casara, S., Penna, E., Quaglino, E., Forni, M., Damasco, C., Pinatel, E., et al. (2012) · The FASEB Journal · doi:10.1096/fj.12-214692 · Cited by 154
MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3
Fan, Z., Cui, H., Xu, X., Lin, Z., Zhang, X., Kang, L., Han, B., Meng, J., Yan, Z., Yan, X., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4457 · Cited by 152
Dahl, K. D. C., Dahl, R. E., Kruichak, J. N., & Hudson, L. G. (2009) · Neoplasia · doi:10.1593/neo.09942 · Cited by 151
Lu, Y., Xiao, J., Lin, H., Bai, Y., Luo, X., Wang, Z., & Yang, B. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1053 · Cited by 151
Antiproliferative Effects by Let-7 Repression of High-Mobility Group A2 in Uterine Leiomyoma
Peng, Y., Laser, J. S., Shi, G., Mittal, K., Melamed, J., Lee, P., & Wei, J. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0370 · Cited by 150
Zheng, L., Qi, T., Yang, D., Qi, M., Li, D., Xiang, X., Huang, K., & Tong, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055719 · Cited by 149
Rapid Generation of MicroRNA Sponges for MicroRNA Inhibition
Kluiver, J. L., Gibcus, J. H., Hettinga, C., Adema, A., van Duijl-Richter, M. K. S., Halsema, N., Ślęzak-Prochazka, I., Ding, Y., Kroesen, B., & van den Berg, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029275 · Cited by 146
Zhang, H., Pu, J., Qi, T., Qi, M., Yang, C., Li, S., Huang, K., Zheng, L., & Tong, Q. (2014) · Oncogene · doi:10.1038/onc.2012.574 · Cited by 144
Androgen-regulated processing of the oncomir MiR-27a, which targets Prohibitin in prostate cancer
Fletcher, C. E., Dart, D. A., Sita-Lumsden, A. R., Cheng, H., Rennie, P. S., & Bevan, C. L. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds139 · Cited by 142
MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1
Lin, Y., Liu, A. Y., Fan, C., Zheng, H., Li, Y., Zhang, C., Wu, S., Yu, D., Huang, Z., Liu, F., et al. (2015) · Scientific Reports · doi:10.1038/srep09995 · Cited by 141
Using artificial microRNA sponges to achieve microRNA loss-of-function in cancer cells
Tay, F. C., Lim, J. K., Zhu, H., Hin, L. C., & Wang, S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.010 · Cited by 139
Cell Cycle Regulation by MicroRNAs in Embryonic Stem Cells
Wang, Y., & Blelloch, R. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0309 · Cited by 139
Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells
Shu, M., Zheng, X., Wu, S., Lu, H., Leng, T., Zhu, W., Zhou, Y., Ou, Y., Lin, X., Lin, Y., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-59 · Cited by 139
Xie, T., Xia, Z., Zhang, N., Gong, W., & Huang, S. (2010) · PubMed · Cited by 138
Bao, W., Wang, H., Tian, F., He, X.-Y., Qiu, M.-T., Wang, J.-Y., Zhang, H.-J., Wang, L.-H., & Wan, X.-P. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-155 · Cited by 138
Yang, H., Liu, P., Zhang, J., Xu, P., Lu, Z., Yu, S., Meng, Y., Tong, W.-M., & Chen, J. (2015) · Oncogene · doi:10.1038/onc.2015.430 · Cited by 138
Koutsaki, M., Spandidos, D. A., & Zaravinos, A. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.022 · Cited by 136
Self-citationLin, J., Teo, S. H., Lam, D. H., Jeyaseelan, K., & Wang, S. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.134 · Cited by 136
Genetic variants in microRNA genes: impact on microRNA expression, function, and disease
Cammaerts, S., Strazisar, M., Rijk, P. D., & Del-Favero, J. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00186 · Cited by 135
MiR-21: an environmental driver of malignant melanoma?
Melnik, B. C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0570-5 · Cited by 134
Zheng, Y. H., Zhang, H., Zhang, X.-J., Feng, D.-D., Luo, X.-Q., Zeng, C.-W., Lin, K.-Y., Zhou, H., Qu, L.-H., Zhang, P., et al. (2011) · Oncogene · doi:10.1038/onc.2011.208 · Cited by 134
Suto, T., Yokobori, T., Yajima, R., Morita, H., Fujii, T., Yamaguchi, S., Altan, B., Tsutsumi, S., Asao, T., & Kuwano, H. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu242 · Cited by 132
miR-221/222 promote malignant progression of glioma through activation of the Akt pathway
Kang, C. (2010) · International Journal of Oncology · doi:10.3892/ijo_00000570 · Cited by 131
microRNA-7: A tumor suppressor miRNA with therapeutic potential
Kalinowski, F. C., Brown, R. A. M., Ganda, C., Giles, K. M., Epis, M. R., Horsham, J. L., & Leedman, P. J. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.05.040 · Cited by 130
Kang (2009) · International Journal of Oncology · doi:10.3892/ijo_00000296 · Cited by 130
The Principles of MiRNA-Masking Antisense Oligonucleotides Technology
Wang, Z. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-863-8_3 · Cited by 129
MicroRNAs as Therapeutic Targets
Czech, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmcibr060065 · Cited by 129
Cited by
Recent Advances in miRNA Delivery Systems
Dasgupta, I., & Chatterjee, A. (2021) · Methods and Protocols · doi:10.3390/mps4010010 · Cited by 307
RNAi therapeutic and its innovative biotechnological evolution
Weng, Y., Xiao, H., Zhang, J., Liang, X.-J., & Huang, Y. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.04.012 · Cited by 286
Improved Loading of Plasma-Derived Extracellular Vesicles to Encapsulate Antitumor miRNAs
Pomatto, M. A. C., Bussolati, B., D’Antico, S., Ghiotto, S., Tetta, C., Brizzi, M. F., & Camussi, G. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.01.001 · Cited by 243
Interplay between miRNAs and host genes and their role in cancer
Liu, B., Shyr, Y., Cai, J., & Liu, Q. (2019) · Briefings in Functional Genomics · doi:10.1093/bfgp/elz002 · Cited by 137
MicroRNA as an Important Target for Anticancer Drug Development
Fu, Z., Wang, L., Li, S., Chen, F., Au-Yeung, K. K.-W., & Shi, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.736323 · Cited by 133
Metadata
- Authors
- GAMBARI, R., BROGNARA, E., SPANDIDOS, D. A., & FABBRI, E.
- Venue
- International Journal of Oncology
- Publisher
- Spandidos Publications
- Published
- 2016-05-04
- Volume
- 49
- Issue
- 1
- Pages
- 5-32
- ISSN
- 1019-6439 (ISSN-L)
- 1791-2423
- OpenAlex
- W2345940501
- Cited by
- 262
- References
- 359
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.